European Heart Journal Submission Process

This page was created from OUP's current European Heart Journal general instructions, EHJ journal pages, Clarivate JCR context, and Manusights internal analysis of cardiovascular manuscripts being positioned for flagship journals. It owns the EHJ process intent: what happens after upload, what triage is testing, and how authors should read Fast Track, transfer, and quiet periods.

This is separate from the European Heart Journal submission guide, which covers readiness before upload. The specific failure pattern we see is a subspecialty cardiology manuscript that is scientifically solid but asks EHJ to infer broad clinical consequence from a narrow title, abstract, or first figure.

This page is about workflow after upload.

Use it when you want to understand:

• what happens once the manuscript enters the EHJ system
• what editorial triage is really testing
• how to interpret delays, reviewer-routing slowdowns, and quiet periods
• what usually causes a paper to stop before full review matters

If you still need to decide whether the package is ready, that belongs on the submission-guide page.

The process usually feels cleaner when the manuscript already arrives with:

• a broad-enough cardiovascular audience case
• a consequence that is visible early in the title, abstract, and first figure
• evidence mature enough for a flagship broad-cardiology screen
• complete methods, declarations, and supporting material
• an article-type choice that the editor does not need to mentally correct

If those pieces are soft, the workflow can feel harsher than authors expect because the system exposes weakness early.

The first stage is not mainly testing whether the study is interesting.

It is testing whether:

• the paper belongs in EHJ rather than a narrower cardiovascular title
• the chosen article type is actually the one the manuscript can sustain
• the consequence is broad enough to justify flagship-editorial attention
• the evidence package supports the breadth of the claim
• the manuscript looks stable enough to justify reviewer time

That is why fast rejection here often means "not broad or mature enough for EHJ," not "bad science."

Authors should think in stages:

• the earliest period is mostly breadth, consequence, and package-stability judgment
• movement into fuller review usually means the hardest flagship screen has been cleared
• later slowdowns often reflect reviewer routing, interpretation questions, or evidence disputes rather than admin delay

The practical point is that the real risk sits early. Once the paper survives that first triage read, the process becomes more about how well the evidence carries the claim.

The first process layer is standard but still meaningful:

• manuscript and figure files
• text abstract and, where required, structured graphical abstract files
• author details
• disclosures and funding
• ethics statements
• supplements and appendices
• cover letter

The package matters because cardiology editors interpret sloppiness as signal. If the manuscript looks disorganized or the supplementary material is hard to use, the paper begins with less trust around it.

For a journal like this, that is a real cost. The file should already look like something built for serious evaluation.

That matters more at EHJ because Clinical Research Articles, Translational Science Articles, and Meta-analyses are expected to arrive with a structured graphical abstract workflow already in motion. If the package looks incomplete there, the editor sees it immediately.

European Heart Journal wants papers that matter to general cardiology readers, not only one narrow subspecialty conversation. Editors are asking:

• does this question matter beyond one procedural or niche context
• is there likely practice, policy, or guideline relevance
• would broad cardiovascular readers care now

If the contribution feels too specialist, the process often stops at triage.

The journal is especially sensitive to papers whose framing is broader than their design can bear. If the manuscript sounds practice-relevant, the evidence needs to feel stable enough for that level of implication.

Editors care about:

• design strength
• scale and generalizability
• endpoint credibility
• limitation honesty
• the relation between claim and evidence

If those are misaligned, the process weakens quickly.

For authors asking for accelerated handling, the editor is also judging whether the paper really is topical, congress-linked, or important enough to justify the special route. Fast Track is not a shortcut for ordinary manuscripts.

Some papers are technically strong but editorially vague. They present an association, a risk model, or a subgroup result without making clear what cardiologists should actually do with it. That is a problem here.

The paper needs a visible consequence:

• change in interpretation
• change in decision logic
• change in prognostic or treatment understanding

Without that, broad-cardiology priority is harder to defend.

The process often slows in a few predictable places.

Papers blending imaging, intervention, outcomes, genomics, and risk modeling can be harder to route quickly. If the right reviewer mix is not obvious, the process stalls.

Single-center studies, narrower cohorts, or retrospective analyses often run into trouble if they are framed as if they should drive broad cardiology practice.

If the editor can see the result but not the practical cardiovascular importance, the paper often struggles to gain momentum.

In our pre-submission review work, European Heart Journal submissions usually get harder for the same four reasons:

• the manuscript sounds broadly important in the cover letter, but the title and abstract still read like a subspecialty paper
• the clinical implication depends on interpretation rather than a decision a general cardiology reader can actually use
• the design is solid for a narrower title but not strong enough for the breadth of the EHJ claim
• the structured abstract or graphical abstract makes a weak consequence more obvious instead of clearer

Use the journal cluster before you submit:

• European Heart Journal journal page
• European Heart Journal journal profile
• How to Choose the Right Journal for Your Paper
• Desk Rejection: What It Means, Why It Happens, and What to Do Next

If the manuscript still feels like it needs a lot of justification to belong here, that usually means the process problem is fit, not mechanics.

The abstract should make clear:

• the cardiology problem
• the cohort or evidence type
• the key result
• the clinical consequence

Editors should not need to infer importance from later sections.

For EHJ Clinical Research Articles, the abstract also has to survive the required Background and Aims / Methods / Results / Conclusions structure and the separate structured graphical abstract text. If the story collapses when forced into those pieces, the package is not ready.

At this level, figures should communicate cleanly to a general cardiology editor, not only to the exact subspecialist audience. If the key logic is buried in dense subgroup detail, the first read becomes harder than it should be.

Your cover letter should frame why this manuscript deserves evaluation in a flagship cardiology journal now. It should explain journal-level consequence, not just summarize the paper.

If Fast Track is justified, this is also where the topicality or congress-timing case must be made.

Supplements should help the editor trust the file:

• methods detail
• sensitivity analyses
• subgroup definitions
• robustness checks
• clarifying tables or model details

They should not feel like a repository of unresolved uncertainty.

That is the real process story. European Heart Journal moves better when the manuscript already looks like a strong general-cardiology contribution before anyone argues about details.

Several patterns repeatedly make the European Heart Journal process rougher.

The paper is written for a subspecialty reader while claiming broad cardiology consequence. Editors see that mismatch quickly.

The title and abstract sound more important than the design can support. When that happens, the paper loses credibility at the exact stage where credibility matters most.

The figures are technically fine but editorially dense. If a broad cardiovascular editor cannot read the practical importance quickly, the process becomes less favorable.

The supplement carries too much unresolved logic. Important model definitions, sensitivity checks, and robustness decisions should support the manuscript, not force the editor to reconstruct it.